The unbiased clustering function of single-cell analysis tools allowed us to recognize a newly identified BC subset, natural killer (NK)-like BCs (K-BC) which were characterized by the co-expression of CD56 and CD19, markers of NKs and BCs. The gene discussed is CD19; the disease is breast cancer.